MANUELA BERRY: Open Payments
NPI 1063070308 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 25 payments from 5 companies in 2025. Trend: 2023 $660 · 2024 $645 · 2025 $382
Food & beverage: $382
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $195 |
| GlaxoSmithKline, LLC. | 3 | $65 |
| Novo Nordisk Inc | 3 | $59 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
Products named: VRAYLAR, LINZESS, Ozempic, QULIPTA, GEMTESA, JARDIANCE, BLUJEPA, UBRELVY.
Industry payments across TX — which companies pay providers there.
